Abstract
Some of the major public anxieties in public health matters in recent years, as well as some of the greatest medical achievements, have concerned the class of medicines known as ‘biologicals’. Take, for example, blood and blood products. They are an essential and life-saving component of everyday medical practice. But the AIDS epidemic provided painful evidence of how disease could be transmitted by donated blood or products made from it, such as clotting factors for the treatment of haemophilia (Berridge, 1996, p. 134). Subsequently there have been public scandals or public inquiries in several countries about the safety of blood and blood products and the effectiveness of controls (Baiter, 1999; Health Canada, 1997).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
